RLYB earnings: a negative outcome, -8.7%

On March 12, 2024, Rallybio Corp reached its earnings. The result was a negative outcome, and the stock moved -8.7% in the window around the event. It had already run +5.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.